methods: ADAPT-DES was a prospective, multicenter registry of patients successfully treated with one or more drug-eluting stents. Non-ACS pts were classified in two groups according to the complexity of the PCI (complex PCI was defined as ≥3 stents implanted, use of rotational atherectomy, saphenous vein graft, bifurcation with two stents implanted, and left main PCI) and stratified according to platelet reactivity (low: PRU <208 vs. high: PRU ≥208). Two-year outcomes were compared. results: Among a total of 8,582 pts enrolled, 4,103 (47.8%) were non-ACS pts, with 1,241 (30.2%) who underwent complex PCI. Twoyear adverse events were the highest in patients with complex PCI and PRU≥208, and the lowest in patients with non-complex PCI and PRU <208 (Table) . After multivariable analysis, adjusting for PRU, complex PCI was an independent predictor of ARC-defined ST 
